• Temozolomide and ATRX in Glioma Evidence

  2026-10-05

  Temozolomide is a small-molecule alkylating agent that can reveal how glioma genotype shapes DNA damage response. This evidence-focused analysis examines the ATRX–RTK inhibitor study, clarifies what combination toxicity does and does not establish, and defines boundaries for DNA repair mechanism research.

• Letrozole: From Enzyme Target to Evidence

  2026-10-04

  Letrozole is a reversible, non-steroidal aromatase inhibitor whose value in research depends on connecting target engagement with endocrine, receptor, and cellular outcomes. This evidence-centered guide explains how to interpret breast cancer, neural, and hypothalamic-pituitary findings without overstating what any single model can prove.

• Hyaluronic Acid Sodium Salt: Evidence and Limits

  2026-10-03

  This evidence-focused overview explains what hyaluronic acid sodium salt is, how it was used in a recent preclinical study of Pseudomonas aeruginosa lung injury, and what the findings do—and do not—establish. It separates material properties, nanoparticle effects, mechanism, translational relevance, and evidence limitations.

• BCA Protein Quantification Kit: Practical Guide

  2026-10-02

  The Bicinchoninic Acid Assay (BCA) Protein Quantification Kit K4102 provides sensitive total-protein measurement for dilute samples, including cell lysates and many detergent-containing preparations. It is intended for scientific research and sample normalization, not diagnostic, clinical, or medical testing.

• Phebestin and Bestatin: Antiplasmodial Aminopeptidase

  2026-10-01

  The reference study shows that phebestin, a bestatin-related aminopeptidase inhibitor, combines nanomolar activity against chloroquine-sensitive and chloroquine-resistant Plasmodium falciparum with measurable efficacy in murine malaria models. Its integrated parasite-stage assays, washout experiments, docking analysis, and in vivo testing provide a useful framework for evaluating aminopeptidase-directed antiplasmodial compounds while highlighting important limits in target validation and cross-species translation.

• Halazone: From Water Chemistry to Nerve Biophysics

  2026-10-01

  Halazone is an antimicrobial sulfonamide derivative whose chemistry connects rapid water disinfection with a distinctive sodium-current phenotype. This evidence-led guide explains how to choose assays, interpret HOCl-driven activity, and avoid overextending neurophysiological findings into unsupported mechanisms.

• Letrozole Workflows for Aromatase Research

  2026-09-30

  Letrozole enables controlled estrogen-depletion experiments spanning aromatase biochemistry, hormone-responsive breast cancer models, and neuroendocrine feedback studies. This practical guide combines concentration planning, pathway-specific readouts, comparison with estrogen-receptor modulators, and troubleshooting for more reproducible results.

• DdmDE Plasmid Clearance by ssDNA Loop Extrusion

  2026-09-30

  Yang et al. define a dynamic mechanism in which the DdmE–DdmD defense module recognizes target DNA, unwinds it bidirectionally, extrudes single-stranded DNA, and then cleaves the exposed strands. The study clarifies how a DNA-guided Argonaute can cooperate with an accessory helicase-nuclease to eliminate plasmids, while offering a framework for analyzing force-dependent nucleic-acid defense systems.

• Letrozole: Reliable Aromatase-Inhibition Workflows

  2026-09-29

  A scenario-based guide to using Letrozole (SKU A1307) in cell viability, proliferation, and endocrine-response assays. It connects mechanism, solvent control, exposure design, data interpretation, and practical product-selection criteria for more reproducible breast cancer research workflows.

• D-Mannitol: Practical Research Workflow Guide

  2026-09-28

  D-Mannitol (SKU B2090) is a water-soluble biochemical reagent for controlled osmotic regulation research, renal function studies, and diuretic mechanism investigation. It is intended for defined laboratory workflows, not as a substitute for a validated clinical formulation, and prepared solutions should be used promptly rather than stored long term.

• ARv7 and EPI-001 in Triple-Negative Breast Cancer

  2026-09-28

  This study combined patient-cohort analyses with experiments in MDA-MB-231 cells to examine androgen receptor (AR) and AR variant 7 (ARv7) in triple-negative breast cancer (TNBC). ARv7 expression was associated with unfavorable outcomes, while Enzalutamide and EPI-001 altered migration- and epithelial-to-mesenchymal-transition-related markers in vitro, supporting further investigation rather than establishing a treatment strategy.

• UBR1 and UBR2 as Mammalian ER Stress Sensors

  2026-09-27

  The study identifies the N-recognin E3 ligases UBR1 and UBR2 as regulators of mammalian ER stress tolerance: they are normally ubiquitinated and degraded, but become more stable during ER stress. Cells lacking both proteins are more susceptible to stress-induced apoptosis, linking the N-degron pathway to ER protein quality control without yet establishing how these proteins sense stress.

• Angiotensin (1-7): Product Identity in ACE2 Assays

  2026-09-26

  Angiotensin (1-7) is both an ACE2-generated peptide and a Mas receptor signaling probe, but those roles should not be conflated in enzyme assays. Explore what a recent ACE2 peptidase study reveals about assay interpretation, peptide identity, and designing more informative experiments.

• Indole-3-pyruvic acid: workflows for auxin research

  2026-09-25

  Use Indole-3-pyruvic acid to probe feedback control of auxin biosynthesis, then adapt the compound for carefully controlled immune-cell studies. This guide separates published findings from practical starting conditions and explains how to troubleshoot instability, dosing, and cross-domain interpretation.

• Brazilin Limits MGO-Induced Endothelial Injury

  2026-09-25

  A 2026 study links brazilin’s protection against methylglyoxal-induced endothelial injury to DOHH-dependent eIF5A hypusination and reduced AMPK/mTOR-associated autophagy and apoptosis. Pharmacological perturbations and experiments in diabetic mice support the proposed pathway, while leaving questions about pathway specificity, autophagic flux, and translation to human vascular disease.

7972 records 1/532 page Next 12345 下5页 Last page